v3.26.1
Consolidated Statements of Changes in Shareholders' Equity
HKD ($)
shares
USD ($)
shares
Class A and Class B Ordinary Shares
HKD ($)
shares
Class A and Class B Ordinary Shares
USD ($)
shares
Additional Paid-in Capital
HKD ($)
Additional Paid-in Capital
USD ($)
Amounts due from related parties
HKD ($)
Amounts due from related parties
USD ($)
Retained Earnings (Accumulated Deficit)
HKD ($)
Retained Earnings (Accumulated Deficit)
USD ($)
Accumulated Other Comprehensive Loss
HKD ($)
Accumulated Other Comprehensive Loss
USD ($)
Outstanding shares, beginning balance (in shares) at Dec. 31, 2022 | shares [1]     1,448,125 1,448,125                
Beginning balance at Dec. 31, 2022 $ 10,425,898   $ 3,900   $ 2,042,379   $ 0   $ 8,478,877   $ (99,258)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 6,628,881               6,628,881      
Dividend declared (5,329,213)               (5,329,213)      
Foreign currency translation adjustments 17,866                   17,866  
Outstanding shares, ending balance (in shares) at Dec. 31, 2023 | shares [1]     1,448,125 1,448,125                
Ending balance at Dec. 31, 2023 11,743,432   $ 3,900   2,042,379   0   9,778,545   (81,392)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Common stock issued (in shares) | shares [1]     208,360 208,360                
Common stock issued 48,873,969       48,873,969              
Deferred IPO costs (4,497,801)       (4,497,801)              
Net income (loss) (20,210,992)               (20,210,992)      
Foreign currency translation adjustments $ 3,964                   3,964  
Outstanding shares, ending balance (in shares) at Dec. 31, 2024 | shares 1,656,459 [2] 1,656,459 [2] 1,656,485 [1] 1,656,485 [1]                
Ending balance at Dec. 31, 2024 $ 35,912,572   $ 3,900   46,418,547   0   (10,432,447)   (77,428)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Common stock issued (in shares) | shares [1]     48,520,000 48,520,000                
Common stock issued 3,782,738,724       3,782,738,724              
Pre-funded warrant 115,440,000       115,440,000              
Net income (loss) 78,744,704 $ 10,117,135             78,744,704      
Foreign currency translation adjustments $ (465,751) $ (91,897)                 (465,751)  
Outstanding shares, ending balance (in shares) at Dec. 31, 2025 | shares 50,176,485 [2] 50,176,485 [2] 50,176,485 [1] 50,176,485 [1]                
Ending balance at Dec. 31, 2025 $ 4,012,370,249 $ 515,510,159 $ 3,900 $ 500 $ 3,944,597,271 $ 506,802,677 $ 0 $ 0 $ 68,312,257 $ 8,776,772 $ (543,179) $ (69,790)
[1] Giving retroactive effect to the 8 for 1 share consolidation effected on July 10, 2025.
[2] Giving retroactive effect to the 8 for 1 share consolidation effected on July 10, 2025.